Marybeth S. Hughes

National Institutes of Health — United States

Medicine · Health Sciences

41h-index25.2kcitations156works4.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(58), Immunotherapy and Immune Responses(53), Cancer Immunotherapy and Biomarkers(32), Neuroendocrine Tumor Research Advances(31), Virus-based gene therapy research(24)

Publications156 total

Single-cell RNA-seq of small-intestinal neuroendocrine tumors reveals the cell of origin and gene expression of early tumor development
Cell Reports·2025Open Access
Pancreaticojejunostomy with duct-to-mucosa versus invagination techniques: a propensity-score matching analysis based on pancreatic duct size and gland texture
The American Journal of Surgery·2025
Treatment of Intractable Cancer Pain with Resiniferatoxin — An Interim Study
NEJM Evidence·2025· 9 cited
Surgical Management of Gastroenteropancreatic Neuroendocrine Tumors
Cancers·2025· 6 citedOpen Access
Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy
Frontiers in Immunology·2024· 4 citedOpen Access
Management of Pancreatic Neuroendocrine Tumors: Surgical Strategies and Controversies
Endocrine Practice·2024· 9 cited
Association of Women Surgeons presidential address: It takes a village
The American Journal of Surgery·2023
Performance of capsule endoscopy for the detection of small intestinal neuroendocrine tumors in familial carcinoid: a prospective single-site study
Gastrointestinal Endoscopy·2023· 1 cited
Presentation of Gastrointestinal Stromal Tumor, Pancreatic Adenocarcinoma, and Gastric Adenocarcinoma in a Woman With No Identifiable Genetic Abnormalities
The American Surgeon·2023· 1 cited
Malignant primary melanoma of the colon: a case report
Journal of Surgical Case Reports·2023Open Access
Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2023Open Access
Data from CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
2023Open Access
Data from CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
2023Open Access
Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplemental figure 4 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplemental figure 5 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2023Open Access
Data from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplemental figure 1 from Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
2023Open Access
Supplementary Data from CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Steven A. Rosenberg(29), Richard M. Sherry(26), Udai S. Kammula(26), Richard E. Royal(17), Mark E. Dudley(16), Nicholas P. Restifo(16), James Chih‐Hsin Yang(15), Giao Q. Phan(15), Seth M. Steinberg(12), Donald E. White(12), John R. Wunderlich(11), James C. Yang(11), Carolyn M. Laurençot(9), Suzanne L. Topalian(8), Paul F. Robbins(8), Kathleen E. Morton(8), Catherine Lévy(8), Steven K. Libutti(8), Steven A. Feldman(7), H. Richard Alexander(7)